However, when ligands expressed by tumor cells or immune infiltrating cells in the TME bind to PD-1, an intracellular inhibitory signal is transduced that halts the activation process and impairs T-cell effector functions [122]. The gene discussed is PDCD1; the disease is neoplasm.